about
Bortezomib for the treatment of mantle cell lymphoma: an updateThe role of targeted treatment in mantle cell lymphoma: is transplant dead or alive?The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma.Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsB-cell receptor signalling and its crosstalk with other pathways in normal and malignant cellsDetailed Functional and Proteomic Characterization of Fludarabine Resistance in Mantle Cell Lymphoma CellsBcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199.Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma.Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents.Do mantle cell lymphomas have an 'Achilles heel'?Requirement for CDK6 in MLL-rearranged acute myeloid leukemia.Elevated soluble IL-2Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphomaSubclonal evolution of a classical Hodgkin lymphoma from a germinal center B-cell-derived mantle cell lymphoma.Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytes.Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinibArsenic trioxide rewires mantle cell lymphoma response to bortezomibHarnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.Identification of miR-15b as a transformation-related factor in mantle cell lymphomaMolecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma.Bortezomib for the treatment of non-Hodgkin's lymphomaThe 2016 revision of the World Health Organization classification of lymphoid neoplasms.Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma.A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas.Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphomaPhospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma.Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20 monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphomaIndolent mantle cell lymphoma.Therapy-related B lymphoblastic leukemia with t(4;11)(q21;q23)/AF4-MLL in a patient with mantle cell lymphoma after recent aggressive chemotherapy: a unique case report.Current regimens and novel agents for mantle cell lymphoma.A rare presentation of in situ mantle cell lymphoma and follicular lymphoma: a case report and review of the literatureClinicopathologic features and management of blastoid variant of mantle cell lymphoma.New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies.Novel agents in mantle cell lymphoma.Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.Mantle cell lymphoma--a spectrum from indolent to aggressive disease.Treatment options for mantle cell lymphoma.Eosinophilic pustular folliculitis associated with hematological disorders: A report of two cases and review of Japanese literature.Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.
P2860
Q26738940-59123EE2-D98D-4C87-9B22-D8E2F5BE1740Q26772907-C6479BF0-5AD4-492F-B4E6-8FAE78F8C524Q27852536-D3B05913-AAD5-4CDA-BFDC-15E5321E8E8EQ28075606-1B1997E7-A30B-4979-B2FB-32683A1F4B4DQ28245018-8B4B23EE-CB91-4ABD-B453-DAF0FBB028E8Q28547322-0DA490C5-86DC-4696-ACBF-AC5AB8B266E8Q30395557-2EF45831-785E-41A3-85F5-42106E1AF1A1Q33587128-01192D12-CD71-4DC8-B567-FDBD62A5A881Q33890300-DD09D545-4B56-455A-93D2-689FD193C914Q34090009-28E20A2F-31BA-4671-9FFA-FE40450EC920Q34310186-87A6395D-1345-4FF1-834C-0666A863C70BQ34626318-87F954F2-4567-48A1-9C53-6ED4969274D6Q34912276-B8FC2697-6E72-4710-B288-E1CDE4E54E9EQ35812755-1BE16A60-2762-46DD-80DB-00357E684943Q36091288-DACA42B3-D10B-41FE-8651-1A825E2AADFAQ36358595-DC95FBE8-F642-4784-8EA0-1479E3EDDF74Q36459323-3C65FBB1-BFF4-4E5F-9E9F-ACE79856B29EQ36498093-906CC79C-1A49-4D6B-941E-1A4F74EDA21AQ36772172-06EAFD9D-35B4-4E22-9ED8-1CEE3C215BBDQ36868056-ACCF9015-05DC-4C27-B97D-B121F673E322Q36920426-C6E2610D-043A-4B48-9DF2-7DFE64FA7245Q37076425-0099DA9A-6326-457D-BC3B-74E0CD86DDA1Q37259187-8C1432C5-B30F-45E4-B441-6929E367CC4BQ37318226-4FC61DD6-91B2-4ECD-A11B-FF498986A48EQ37404843-204D66C4-A300-4B69-92E2-EDBD93C47CBAQ37427684-7E4256C6-8695-4A84-A61F-FFA33FFAD476Q37520396-E36FFD3B-2142-4781-A91A-FF613B8B2E60Q37718466-6156F8C3-CA7A-4EE6-99E7-244C29313D69Q38127446-E6DCEB03-C6D4-4A96-A026-F6C2532A8B08Q38211030-7803D321-B8B8-4814-8125-0063A1731CA2Q38224186-A4EE9DE8-DB81-4C09-AC80-1C6312C4DBB2Q38283586-81A961BE-83AE-48D7-8E6B-6258B6135202Q38369665-5A8C87AD-2E23-4132-B97D-00EE9DEDAD4CQ38375603-E5A54AD6-9E3D-40BE-B15F-03A5F2E47657Q38516704-3A41CFDE-8CB5-4576-871E-D6F057E75887Q38535489-B69229C1-186A-4574-96F8-ECED14B9BCFCQ38571854-19B8DB9F-951E-41FC-937C-126D94618924Q38584922-6DF30B72-12D3-4E1D-AC8F-5763659E2AB1Q38585259-F08E7F20-D2DE-45DC-AAC9-7DCF5608D2B5Q38663689-7A20B73E-5C6E-43DD-AB9F-E57CB1518F7D
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Molecular pathogenesis of mantle cell lymphoma.
@ast
Molecular pathogenesis of mantle cell lymphoma.
@en
type
label
Molecular pathogenesis of mantle cell lymphoma.
@ast
Molecular pathogenesis of mantle cell lymphoma.
@en
prefLabel
Molecular pathogenesis of mantle cell lymphoma.
@ast
Molecular pathogenesis of mantle cell lymphoma.
@en
P2860
P50
P356
P1476
Molecular pathogenesis of mantle cell lymphoma.
@en
P2860
P304
P356
10.1172/JCI61272
P407
P577
2012-10-01T00:00:00Z